Addressing hepatitis delta in primary care practices in the US: a narrative review
CONCLUSIONS: PCPs can be a valuable point of care for patients to access HDV/HBV screening, HBV immunization, and education, and can comanage patients with HBV and/or HDV infection.PMID:38487951 | DOI:10.1080/03007995.2024.2318004 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 15, 2024 Category: Research Authors: Tatyana Kushner Richard R Andrews Source Type: research

Evaluation of effect of brief-intensive cognitive behavior therapy on symptoms severity in relation with catastrophic cognition in patients with panic disorder: a randomized controlled trial
CONCLUSIONS: The study showed that brief-intensive CBT is an effective technique for reducing the severity of symptoms among PD patients. But, it was not effective to improve the cognitive level in PD patients at one month.PMID:38465410 | DOI:10.1080/03007995.2024.2328651 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Rasoul Sabri Piro Perjan Hashim Taha Source Type: research

Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data
Conclusion: Patients with ITP receiving rituximab were more likely to need other ITP therapies but did not experience higher risk of bleeding compared to those receiving eltrombopag or romiplostim. Benefits, risks, cost-effectiveness, and patient preference should all be considered in optimizing second-line therapy for ITP.PMID:38465414 | DOI:10.1080/03007995.2024.2328653 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Yi Liang Karen Rascati Jamie C Barner Kenneth A Lawson Radhika Nair Source Type: research

Evaluation of effect of brief-intensive cognitive behavior therapy on symptoms severity in relation with catastrophic cognition in patients with panic disorder: a randomized controlled trial
Conclusions: The study showed that brief-intensive CBT is an effective technique for reducing the severity of symptoms among PD patients. But, it was not effective to improve the cognitive level in PD patients at one month.Trial Registration: The study received ethical approval from the Duhok Directorate General of Health registered with the reference number 1808202 l-8-5 on August 18, 2021.PMID:38465410 | DOI:10.1080/03007995.2024.2328651 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Rasoul Sabri Piro Perjan Hashim Taha Source Type: research

Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data
Conclusion: Patients with ITP receiving rituximab were more likely to need other ITP therapies but did not experience higher risk of bleeding compared to those receiving eltrombopag or romiplostim. Benefits, risks, cost-effectiveness, and patient preference should all be considered in optimizing second-line therapy for ITP.PMID:38465414 | DOI:10.1080/03007995.2024.2328653 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Yi Liang Karen Rascati Jamie C Barner Kenneth A Lawson Radhika Nair Source Type: research

Evaluation of effect of brief-intensive cognitive behavior therapy on symptoms severity in relation with catastrophic cognition in patients with panic disorder: a randomized controlled trial
Conclusions: The study showed that brief-intensive CBT is an effective technique for reducing the severity of symptoms among PD patients. But, it was not effective to improve the cognitive level in PD patients at one month.Trial Registration: The study received ethical approval from the Duhok Directorate General of Health registered with the reference number 1808202 l-8-5 on August 18, 2021.PMID:38465410 | DOI:10.1080/03007995.2024.2328651 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Rasoul Sabri Piro Perjan Hashim Taha Source Type: research

Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data
Conclusion: Patients with ITP receiving rituximab were more likely to need other ITP therapies but did not experience higher risk of bleeding compared to those receiving eltrombopag or romiplostim. Benefits, risks, cost-effectiveness, and patient preference should all be considered in optimizing second-line therapy for ITP.PMID:38465414 | DOI:10.1080/03007995.2024.2328653 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Yi Liang Karen Rascati Jamie C Barner Kenneth A Lawson Radhika Nair Source Type: research

Evaluation of effect of brief-intensive cognitive behavior therapy on symptoms severity in relation with catastrophic cognition in patients with panic disorder: a randomized controlled trial
Conclusions: The study showed that brief-intensive CBT is an effective technique for reducing the severity of symptoms among PD patients. But, it was not effective to improve the cognitive level in PD patients at one month.Trial Registration: The study received ethical approval from the Duhok Directorate General of Health registered with the reference number 1808202 l-8-5 on August 18, 2021.PMID:38465410 | DOI:10.1080/03007995.2024.2328651 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Rasoul Sabri Piro Perjan Hashim Taha Source Type: research

Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data
Conclusion: Patients with ITP receiving rituximab were more likely to need other ITP therapies but did not experience higher risk of bleeding compared to those receiving eltrombopag or romiplostim. Benefits, risks, cost-effectiveness, and patient preference should all be considered in optimizing second-line therapy for ITP.PMID:38465414 | DOI:10.1080/03007995.2024.2328653 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 11, 2024 Category: Research Authors: Yi Liang Karen Rascati Jamie C Barner Kenneth A Lawson Radhika Nair Source Type: research

Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe
Conclusions: The extemporaneous combination of nebivolol and amlodipine is commonly prescribed in Europe, however adherence to the therapy is poor. The development of a single-pill combination of nebivolol and amlodipine may improve adherence by reducing the number of pills administered to patients and thus simplifying treatment regimens.PMID:38459774 | DOI:10.1080/03007995.2024.2328652 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - March 9, 2024 Category: Research Authors: Giovambattista Desideri Riccardo Cipelli Valeria Pegoraro Claudio Ripellino Marco Miroddi Suada Meto Mario Gori Paolo Fabrizzi Source Type: research

Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan
CONCLUSION: We have clarified the frequency of diagnostic tests related to PH/ES and the incidence of PH/ES in patients with ACHD in clinical practice in Japan, including non-specialist institutions for PH.PMID:38420663 | DOI:10.1080/03007995.2024.2323632 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - February 29, 2024 Category: Research Authors: Tomoko Ishizu Yasuhiro Hayashi Natsuko Tokushige Junichi Omura Source Type: research

Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan
Conclusion: We have clarified the frequency of diagnostic tests related to PH/ES and the incidence of PH/ES in patients with ACHD in clinical practice in Japan, including non-specialist institutions for PH.PMID:38420663 | DOI:10.1080/03007995.2024.2323632 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - February 29, 2024 Category: Research Authors: Tomoko Ishizu Yasuhiro Hayashi Natsuko Tokushige Junichi Omura Source Type: research